<DOC>
	<DOCNO>NCT01264224</DOCNO>
	<brief_summary>1 . Primary Objective : - To evaluate safety tolerability single multiple oral dose PAC-14028 healthy male volunteer . 2 . Secondary Objective : - To evaluate pharmacokinetics pharmacodynamics single multiple oral dose PAC-14028 healthy male volunteer .</brief_summary>
	<brief_title>PAC-14028 Healthy Male Volunteers</brief_title>
	<detailed_description />
	<criteria>1 . Healthy men age 20 45 year time screen 2 . Whose weight 50kg , less 90 kg , whose body mass index ( BMI ) 19.0 kg/m^2 less 27 kg/m^2 BMI ( kg/m^2 ) = weight ( kg ) / { height ( ) } ^2 3. Who voluntarily decide study participation receive detailed explanation study fully understand provide write consent compliance study requirement include proper contraception . 1. Who clinically significant medical history disease involve liver , kidney , neurological system , respiratory system , endocrine system , urinary system , cardiovascular system , psychical disorder blood tumor 2. Who gastrointestinal disease operation history may interfere study drug absorption ( however , except simple appendectomy hernioplasty ) 3. Who history hypersensitivity allergy drug ( aspirin , antibiotic , etc ) 4. Who take prescribed drug , herbal agent crude drug within 2 week study drug administration , take overthecounter ( OTC ) drug vitamin ( Investigators determine eligibility consider effect drug safety pharmacokinetic result case inclusion/exclusion criterion satisfy . ) 5. Who drug abuse history positive result urine screening test ( cannabinoid , opioid , amphetamine , cocaine , barbiturate , benzodiazepine ) 6 . Smoker stop smoke within previous 1 month show positive result cotinine test . 7. Who confirm positive serological test ( HBs antigen , HCV antibody HIV antibody ) 8. Who consistently consume alcohol ( 21 units/week , 1 unit = 10 g pure alcohol ) 9. Who participate clinical study within 12 week study drug administration ( however , last dosing day consider end clinical study . ) 10. Who bleed blood collection donation 400 mL within 12 week study drug administration 11 . Whose vital sign measure sit position rest least 5 minute follow Low blood pressure ( Systolic pressure : 90 mmHg less , Diastolic pressure : 50 mmHg less ) High blood pressure ( Systolic pressure : 140 mmHg high , Diastolic pressure : 90 mmHg less ) 12. Who determine ineligible study participation investigator reason include clinical lab test ECG result .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>